462sek
2,7 %
Date:2025-08-13Time:10:24:16Latest report:Q1-2025List:Small CapTicker:ONCO
Market Cap:1 045 msekEnterprise Value:1 056 msekNet Sales:39,8 msekEarnings:-277,5 msekEmployees:0ISIN:SE0009414576

Ratios

10-year key figure history for Oncopeptides turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Oncopeptides with index and moving average MA50 and MA200.

Stockprice:4,62
MA50:3,15
MA200:2,04
Price/MA200:127,2 %
RSI (14):61,0
Price/MA50:47,2 %

Description

Oncopeptides is a biotech company that develops drugs for difficult-to-treat hematological diseases. The company uses its PDC platform to develop peptide-linked drugs that selectively deliver cytotoxic drugs into cancer cells. The company has drugs in commercialization and several drug candidates under development. Oncopeptide's head office is located in Stockholm.

Biotechnology